VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC
Aktie · US92532F1003 · VRTX · 882807 (XNAS)
Übersicht Finanzkennzahlen
450,50 USD
0,90 % 4,01 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:40

Aktuelle Kurse von VERTEX PHARMACEUTICALS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
VRTX
USD
06.06.2025 20:40
450,50 USD
443,82 USD
+1,51 %
XETR: XETRA
XETRA
VX1.DE
EUR
06.06.2025 15:35
393,10 EUR
389,55 EUR
+0,91 %
XLON: London
London
0QZU.L
USD
06.06.2025 15:14
448,32 USD
443,82 USD
+1,01 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 1,91 % 0,10 % -7,25 % -2,87 % -6,88 % 69,56 %

Profil de l'entreprise pour VERTEX PHARMACEUTICALS INC Action

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Fonds investis

Les fonds suivants ont investi dans : VERTEX PHARMACEUTICALS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
1.695,46
Part (%)
3,98 %
Fonds
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. en millions
1.478,90
Part (%)
1,14 %
Fonds
iShares Edge MSCI World Minimum Volatility ESG UCITS ETF EUR Hedged (Acc)
Vol. en millions
645,34
Part (%)
1,14 %
Fonds
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. en millions
19.976,49
Part (%)
1,14 %
Fonds
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. en millions
1.137,69
Part (%)
1,10 %

Données de l'entreprise

Nom VERTEX PHARMACEUTICALS INC
Société Vertex Pharmaceuticals Incorporated
Symbole VRTX
Site web https://www.vrtx.com
Marché d'origine XNAS NASDAQ
WKN 882807
ISIN US92532F1003
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Reshma Kewalramani FASN, M.D.
Capitalisation boursière 110 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 6,1 T
Adresse 50 Northern Avenue, 02210 Boston
Date d'introduction en bourse 2007-12-28

Fractionnements d'actions

Date Fractionnement
24.08.2000 2:1

Symboles boursiers

Nom Symbole
Frankfurt VX1.F
London 0QZU.L
NASDAQ VRTX
XETRA VX1.DE

Autres actions

Les investisseurs qui détiennent VERTEX PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
ADOBE INC
ADOBE INC Action
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMAZON.CO INC
AMAZON.CO INC Action
APPLE INC
APPLE INC Action
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Action
META PLATFORMS INC
META PLATFORMS INC Action
MICROSOFT CORP
MICROSOFT CORP Action
NORBIT ASA          NK-,1
NORBIT ASA NK-,1 Action
NVIDIA CORP
NVIDIA CORP Action
PAYPAL INC
PAYPAL INC Action
REDOX LTD.
REDOX LTD. Action
ST.GRID OVERS.I. 13/43
ST.GRID OVERS.I. 13/43 Obligation
TESLA INC
TESLA INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025